NCCN 2026 Annual Cancer Conference
Analysis based on 7 articles · First reported Apr 01, 2026 · Last updated Apr 02, 2026
The conference by National Comprehensive Cancer Network highlights ongoing advancements in cancer treatment and care delivery, which could positively impact pharmaceutical and biotechnology companies involved in oncology research and development. Discussions on global cancer care and operational efficiency may influence investment in healthcare infrastructure and technology.
The National Comprehensive Cancer Network (NCCN) hosted its 2026 Annual Conference in Orlando, Florida, bringing together over a thousand oncology professionals. The event featured educational sessions on breakthroughs in cancer prevention and treatment, clinical guideline updates, and discussions on critical issues in care delivery. Key topics included the rising incidence of cancer in younger people, global strategies for improving cancer outcomes, and operational excellence in cancer care, including the role of artificial intelligence and electronic health records. Crystal S. Denlinger, CEO of NCCN, emphasized collaboration, while Ted Lieu and Anu K. Agrawal discussed specific challenges and opportunities in patient care and global initiatives. Lawrence N. Shulman highlighted the need for efficiency in oncology practices. The conference also showcased over 300 original research abstracts and collaborations with entities like the American Cancer Society and the African Cancer Coalition.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard